SynthesisFrontiers in oncology2022

Tryptophan 2,3-dioxygenase may be a potential prognostic biomarker and immunotherapy target in cancer: A meta-analysis and bioinformatics analysis.

Yanyan Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.